Equities

Bio View Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BIOV:TLV

Bio View Ltd

Actions
Health CareMedical Equipment and Services
  • Price (ILa)17.40
  • Today's Change1.60 / 10.13%
  • Shares traded15.80k
  • 1 Year change-45.96%
  • Beta0.2194
Data delayed at least 20 minutes, as of Mar 04 2026 08:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bio-View Ltd. is an Israel-based company that operates within the medical devices industry. The Company focuses on developing, manufacturing, and marketing automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories. One of the key products offered by the Company is the Accord Plus. This product is an automatic fluorescent imaging system that scans, analyzes, and sorts a range of Fluorescence In Situ Hybridization (FISH) and karyotype samples in real-time. The primary goal of this technology is to facilitate the identification of various chromosomal aberrations, such as amplifications, translocations, inversions, and deletions, under fluorescent light.

  • Revenue in ILS (TTM)17.88m
  • Net income in ILS-9.67m
  • Incorporated1998
  • Employees33.00
  • Location
    Bio View Ltd3 Pekeris St.,REHOVOT 7670203IsraelISR
  • Phone+972 89366868
  • Fax+972 89366869
  • Websitehttps://bioview.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Human Xtensions Ltd105.00k-9.37m4.87m3.00--1.48--46.38-0.3489-0.34890.0040.12280.00841.410.09735,000.00-75.17-44.43-97.96-49.43-2,663.8143.40-8,927.62-577.623.97--0.00---86.57-44.1037.30---64.33--
Nextgen Biomed Ltd0.00-9.55m8.46m187.00---------0.9109-0.91090.00-0.75840.00-------944.77-65.21---74.65-----------40.21--------65.53------
Erika Carmel Tech Ltd39.63m-11.45m21.15m----1.58--0.5335-0.11-0.110.38050.12861.040.90926.87---30.04-18.36-53.79-26.3761.0386.48-28.90-18.900.6648-12.590.156--27.03-5.6750.73---33.83--
Bio View Ltd17.88m-9.67m22.38m33.00--1.01--1.25-0.0724-0.07240.13380.16020.50471.233.73541,848.50-27.300.4609-37.170.612746.3659.56-54.090.60941.58-10.310.0854---26.21-6.44-921.93---29.98--
BioLight Life Sciences Ltd21.00k-14.05m30.57m4.00--0.8103--1,455.80-2.95-2.950.00444.170.0006--0.027---47.82-21.57-52.72-22.97-----86,261.91-13,619.35---2.740.0051--85.59-5.9172.55---0.6994--
Allmed Solutions Ltd0.00-12.37m38.91m22.00--1.16-----0.1328-0.13280.000.33620.00----0.00-28.18-9.16-31.98-10.12--55.39---170.44---25.090.0139-------715.47--8.08--
Nissan Medical Industries Ltd640.72m1.00k85.65m406.00--0.42863.020.1337-0.0088-0.008872.7322.000.92964.127.141,578,126.00-0.03613.80-0.07927.1111.3618.52-0.03893.900.49170.89170.3751---9.521.8739.95-12.83-9.20--
Pulsenmore Ltd9.31m-44.00m86.42m63.00--1.13--9.28-6.86-6.861.4511.810.0660.24722.23147,777.80-31.20-23.53-34.52-25.3237.36---472.58-555.166.44-32.440.2476--56.12--37.28--23.66--
Data as of Mar 04 2026. Currency figures normalised to Bio View Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

3.45%Per cent of shares held by top holders
HolderShares% Held
Ayalon Mutual Funds Ltd.as of 30 Nov 20254.30m3.09%
Psagot Mutual Funds Ltd.as of 30 Nov 2025491.08k0.35%
Data from 30 Nov 2025 - 30 Nov 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.